Skip to Main

Search

Results 671 to 680 of 1,032 for ""

UT Southwestern honored for health care leadership development: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-health-care-leadership-training.html

UT Southwestern Medical Center is one of seven health systems in the nation being recognized for its leadership development initiatives, the latest in a series of national and regional employer honors.

Study aims to improve diagnosis of infections following shoulder surgery : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-infections-following-shoulder-surgery.html

The most common bacterial infection to occur after revision shoulder arthroplasty surgery can be diagnosed more accurately by considering how quickly samples of the microbe grow in hospital labs and the level of bacteria that grows, a study partly performed at UT Southwestern shows.

Lipid nanoparticles carry gene-editing cancer drugs past tumor defenses: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/june-gene-editing-cancer-drugs.html

As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult.

UTSW clinical trial sets stage for new paradigm in kidney cancer treatment: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-new-paradigm-in-kidney-cancer-treatment.html

Building upon previous work at UT Southwestern Medical Center, investigators report the results of a clinical trial exploring the role of stereotactic ablative radiation therapy (SAbR) for patients with a handful of metastases, or so-called oligometastatic disease.

UT Southwestern develops nanotherapeutic to ward off liver cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/nanotherapeutic-to-ward-off-liver-cancer.html

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver.

UT Southwestern is nation’s first academic medical center for Chemical Society’s minority recruitment program: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-chemical-societys-minority-recruitment-program.html

UT Southwestern Medical Center has been selected as the nation’s first academic medical center to participate in the American Chemical Society (ACS) Bridge program, designed to increase the number of Black, Latino, and Indigenous students earning doctorates in chemistry.

New cryo-EM images taken at UTSW shed light on Wnt signaling: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-new-cryo-em-images.html

Using UT Southwestern’s Cryo-Electron Microscopy Facility, researchers have captured images of an enzyme for Wnt lipidation, which is pivotal to human development and cancer and crucial for Wnt signaling activation.

UTSW study finds new pain management approach reduced opioid use after C-sections: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/new-pain-management-c-sections.html

For years, women recovering from cesarean section (C-section) deliveries have been given devices that let them, with a button, control the flow of opioid painkillers into their IV line.

UTSW researchers show effectiveness of migraine drug in weight loss: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-migraine-drug-in-weight-loss.html

Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a new study by scientists at UT Southwestern suggests.

UTSW findings advance RAS inhibitors for use in fighting more cancers: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/ras-inhibitors-for-use-in-fighting-more-cancers.html

New findings by UT Southwestern researchers help better understand the how one of the most commonly mutated genetic drivers of cancer passes signals that cause the disease.